Rossari Biotech Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	22,911	20,803	18,306	16,559	14,830	7,093
Revenue Growth (YoY)	16.10%	13.64%	10.55%	11.66%	109.06%	18.21%
Cost of Revenue	15,807	14,393	13,007	11,765	11,121	4,646
Gross Profit	7,104	6,410	5,298	4,794	3,708	2,447
Selling, General & Admin	1,588	1,401	1,098	1,039	726.02	456.35
Other Operating Expenses	2,843	2,466	1,769	1,609	1,200	760.31
Operating Expenses	5,169	4,538	3,471	3,277	2,416	1,445
Operating Income	1,935	1,872	1,827	1,516	1,292	1,002
Interest Expense	-249.86	-178.11	-193.72	-223.15	-126.56	-29.92
Interest & Investment Income	8.57	8.57	22.39	25.21	49.77	42.7
Earnings From Equity Investments	15.32	9.78	1.75	9.57	15.47	4.11
Currency Exchange Gain (Loss)	108.23	108.23	66.77	84.61	62.05	4.86
Other Non Operating Income (Expenses)	23.89	12.94	7.32	5.06	50.8	17
EBT Excluding Unusual Items	1,841	1,834	1,732	1,418	1,344	1,041
Gain (Loss) on Sale of Investments	18.98	18.98	25.68	7.07	12.52	-0.08
Gain (Loss) on Sale of Assets	-0.69	-0.69	18.78	2.83	6.38	4.32
Other Unusual Items	-	-	-	14.67	-	23.02
Pretax Income	1,860	1,852	1,776	1,442	1,363	1,068
Income Tax Expense	482.88	488.07	469.26	369.62	385.8	267.92
Earnings From Continuing Operations	1,377	1,364	1,307	1,073	976.95	800.46
Minority Interest in Earnings	-	-	-	-	-0.21	1.74
Net Income	1,377	1,364	1,307	1,073	976.74	802.2
Net Income to Common	1,377	1,364	1,307	1,073	976.74	802.2
Net Income Growth	1.19%	4.35%	21.85%	9.81%	21.76%	22.94%
Shares Outstanding (Basic)	55	55	55	55	55	52
Shares Outstanding (Diluted)	55	55	55	55	55	52
Shares Change (YoY)	0.10%	0.08%	-0.05%	0.33%	6.37%	5.16%
EPS (Basic)	24.87	24.66	23.67	19.46	17.81	15.56
EPS (Diluted)	24.85	24.63	23.62	19.38	17.70	15.47
EPS Growth	1.10%	4.28%	21.88%	9.49%	14.41%	16.93%
Free Cash Flow	-	-210.69	-880.28	1,187	-88.67	-103.17
Free Cash Flow Per Share	-	-3.81	-15.91	21.44	-1.61	-1.99
Dividend Per Share	-	0.500	0.500	0.500	0.500	0.500
Gross Margin	31.01%	30.81%	28.94%	28.95%	25.01%	34.50%
Operating Margin	8.45%	9.00%	9.98%	9.16%	8.71%	14.13%
Profit Margin	6.01%	6.56%	7.14%	6.48%	6.59%	11.31%
Free Cash Flow Margin	-	-1.01%	-4.81%	7.17%	-0.60%	-1.45%
EBITDA	2,566	2,486	2,418	2,138	1,768	1,230
EBITDA Margin	11.20%	11.95%	13.21%	12.91%	11.92%	17.33%
D&A For EBITDA	630.31	613.57	591.25	621.4	476	227.13
EBIT	1,935	1,872	1,827	1,516	1,292	1,002
EBIT Margin	8.45%	9.00%	9.98%	9.16%	8.71%	14.13%
Effective Tax Rate	25.96%	26.36%	26.42%	25.63%	28.31%	25.08%
Revenue as Reported	22,962	20,843	18,380	16,614	14,950	7,180

Source: S&P Global Market Intelligence. Standard template. Financial Sources.